Chief Accounting Officer
Climb Bio, Inc. (CLYM)Equibles does not estimate personal net worth.
Get an email with a short summary when Climb Bio, Inc. publishes a filing, an earnings call transcript or a press release.
Get CLYM alertsEmily Pimblett is recorded as Chief Accounting Officer at Climb Bio, Inc. (CLYM) since March 10, 2023. Climb Bio, Inc. reported in an 8-K filed June 18, 2025 that Emily Pimblett resigned as Chief Accounting Officer, effective June 30, 2025. Climb Bio, Inc. reported in an 8-K filed March 16, 2023 that Emily Pimblett was appointed principal accounting officer, effective March 10, 2023. Climb Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Climb Bio, Inc. includes Aoife Brennan (CEO, CFO and Board Member), Aoife Brennan, M.B., Ch.B. (CEO and Board Member), Dr. Stephen Thomas (CEO) and 7 others.
“On June 12, 2025, Emily Pimblett, the Company's Senior Vice President, Finance and Chief Accounting Officer, notified the Company of her intention to resign, effective as of June 30, 2025.”
“Effective as of March 10, 2023 (the "Transition Date"), the Board appointed (i) Andrew Levin, Executive Chairman, as the Company's new principal financial officer (in addition to principal executive officer) and (ii) Emily Pimblett, Chief Accounting Officer, as the Company's principal accounting officer.”
2023-03-10–present
2023-03-10–2025-06-30
CLYM
Biotechnology · Healthcare
Chief Accounting Officer
2023-03-10–present
